Literature DB >> 6315349

Effects of forskolin on insulin release and cyclic AMP content in rat pancreatic islets.

D E Wiedenkeller, G W Sharp.   

Abstract

The effects of forskolin, a diterpene stimulator of adenylate cyclase, on cyclic AMP content and insulin release, have been studied in rat pancreatic islets. In the presence of 2.8 mM glucose, 0.3 to 30 microM forskolin gave concentration-dependent increases in cyclic AMP content to as much as seven-fold without causing any significant increase in insulin release. With 5.6 mM glucose, cyclic AMP contents were elevated by forskolin to the same extent as with 2.8 mM glucose but, under these conditions, insulin release was stimulated. 3 microM forskolin was a maximal concentration with respect to insulin release, but not for the elevation of cyclic AMP levels. Concentration-dependent increases in both insulin release and cyclic AMP content were detected over the range of 0.3 to 3 microM forskolin. The effect of forskolin to stimulate insulin release was rapid and was reversible within 15 minutes of removal of the drug. When tested with 16.7 mM glucose, forskolin potentiated both phases of stimulated release, with the greater effect upon the first phase.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6315349     DOI: 10.1210/endo-113-6-2311

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  15 in total

1.  Noradrenaline inhibits exocytosis via the G protein βγ subunit and refilling of the readily releasable granule pool via the α(i1/2) subunit.

Authors:  Ying Zhao; Qinghua Fang; Susanne G Straub; Manfred Lindau; Geoffrey W G Sharp
Journal:  J Physiol       Date:  2010-07-19       Impact factor: 5.182

2.  Modulation of Glucagon-like Peptide-1 (GLP-1) Potency by Endocannabinoid-like Lipids Represents a Novel Mode of Regulating GLP-1 Receptor Signaling.

Authors:  Yu-Hong Cheng; Mei-Shang Ho; Wei-Ting Huang; Ying-Ting Chou; Klim King
Journal:  J Biol Chem       Date:  2015-04-22       Impact factor: 5.157

3.  Substrates for cyclic AMP-dependent protein kinase in islets of Langerhans. Studies with forskolin and catalytic subunit.

Authors:  M R Christie; S J Ashcroft
Journal:  Biochem J       Date:  1985-05-01       Impact factor: 3.857

4.  Morphological changes in pancreatic B-cells after intravenous administration of forskolin.

Authors:  M Zafirova; V Ogneva; P Petkov; O Koparanova
Journal:  Acta Diabetol Lat       Date:  1988 Apr-Jun

5.  Ethanol influence on calcium uptake and insulin release by rat islets.

Authors:  G L Pullen; S P Singh; A K Snyder; R Sethi; V Wahby
Journal:  J Endocrinol Invest       Date:  1987-02       Impact factor: 4.256

6.  Regulation of insulin release in persistent hyperinsulinaemic hypoglycaemia of infancy studied in long-term culture of pancreatic tissue.

Authors:  N Kaiser; A P Corcos; A Tur-Sinai; Y Ariav; B Glaser; H Landau; E Cerasi
Journal:  Diabetologia       Date:  1990-08       Impact factor: 10.122

7.  Abnormal regulation of insulin secretion in the genetically obese (ob/ob) mouse.

Authors:  M Black; H M Heick; N Bégin-Heick
Journal:  Biochem J       Date:  1986-09-15       Impact factor: 3.857

8.  Insulin and glucagon releasing activity of coleonol (forskolin) and its effect on blood glucose level in normal and alloxan diabetic rats.

Authors:  F Ahmad; M M Khan; A K Rastogi; J R Kidwai
Journal:  Acta Diabetol Lat       Date:  1991 Jan-Mar

9.  Effect of forskolin on islet cyclic AMP, insulin secretion, blood glucose and intravenous glucose tolerance in rats.

Authors:  H P Ammon; A B Müller
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-07       Impact factor: 3.000

10.  Regulation of PKD by the MAPK p38delta in insulin secretion and glucose homeostasis.

Authors:  Grzegorz Sumara; Ivan Formentini; Stephan Collins; Izabela Sumara; Renata Windak; Bernd Bodenmiller; Reshma Ramracheya; Dorothée Caille; Huiping Jiang; Kenneth A Platt; Paolo Meda; Rudolf Aebersold; Patrik Rorsman; Romeo Ricci
Journal:  Cell       Date:  2009-01-08       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.